Tiziana Life Sciences Ltd (TLSA)

Sep 30, 2026

A rare disorder’s median survival is 6–9 years. Tiziana seeks FDA rare-disease designation for its nasal drug. - Stock Titan

Sep 30, 2026

Sep 30, 2026

Form 4 Tiziana Life Sciences Ltd For: 30 September By Investing.com - Investing.com Canada

Sep 30, 2026

Sep 30, 2026

Form 4 Tiziana Life Sciences Ltd For: 30 September By Investing.com - Investing.com UK

Sep 30, 2026

Sep 22, 2026

TLSA Reiterated by BTIG -- Price Target Maintained at $7.00 - GuruFocus

Sep 22, 2026

Sep 17, 2026

Tiziana Life Sciences (NASDAQ: TLSA) Enters MOU to Launch RRMS Combination Therapy Trial - Kalkine Media

Sep 17, 2026

Sep 17, 2026

Tiziana (TLSA) lines up MS trial for patients failing current drugs with a nasal antibody twist. - Stock Titan

Sep 17, 2026

Sep 17, 2026

A planned MS trial will test Tiziana’s nasal drug with existing treatment - Stock Titan

Sep 17, 2026

Sep 09, 2026

ADAG Stock Price, Quote & News - Syfe

Sep 09, 2026

Sep 08, 2026

TLSA: Tiziana Life Sciences Ltd Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits

Sep 08, 2026

Sep 03, 2026

Tiziana Life Sciences gets Buy rating from BTIG on Treg-based approach to neurodegeneration - Yahoo Finance

Sep 03, 2026

Sep 03, 2026

Small cap wrap: Tiziana Life Sciences, Thistle Resources, Alvopetro, BioHarvest... - Proactive financial news

Sep 03, 2026

Sep 03, 2026

Tiziana Life Sciences gets Buy rating from BTIG on Treg-based approach to neurodegeneration - Proactive financial news

Sep 03, 2026

Sep 03, 2026

Tiziana Life Sciences initiated with a Buy at BTIG - TipRanks

Sep 03, 2026

Sep 03, 2026

Tiziana Life Sciences initiated with a Buy at BTIG - TipRanks

Sep 03, 2026

Sep 03, 2026

This Occidental Petroleum Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga

Sep 03, 2026

Sep 03, 2026

TLSA Initiated Coverage by BTIG -- Price Target Set at $7.00 - GuruFocus

Sep 03, 2026

Sep 03, 2026

BTIG Initiates Tiziana Life Sciences at Buy With $7 Price Target - marketscreener.com

Sep 03, 2026

Sep 03, 2026

BTIG initiates Tiziana Life Sciences stock with buy on MS drug - Investing.com India

Sep 03, 2026

Sep 03, 2026

BTIG initiates Tiziana Life Sciences stock with buy on MS drug - Investing.com

Sep 03, 2026

Sep 03, 2026

BTIG initiates Tiziana Life Sciences stock with buy on MS drug - Investing.com UK

Sep 03, 2026

Sep 03, 2026

Small cap wrap: Tiziana Life Sciences, Thistle Resources, Alvopetro, BioHarvest... - Proactive financial news

Sep 03, 2026

Aug 24, 2026

Wall Street ends on a mixed note as Dow gains despite semiconductor slump - proactiveinvestors.com.au

Aug 24, 2026

Aug 24, 2026

Market movers: Strategy, Bitmine, Tiziana Life Sciences... - Proactive Investors

Aug 24, 2026

Aug 24, 2026

Tiziana (NASDAQ: TLSA) highlights intranasal ALS trial and MS data - Stock Titan

Aug 24, 2026

Aug 24, 2026

Tiziana Life Sciences Announces Poster Presentation on Phase 2a BANYAN Clinical Trial of Intranasal Foralumab at ALS Nexus 2026 - kommunikasjon.ntb.no

Aug 24, 2026

Aug 24, 2026

Tiziana Life Sciences Ltd. - Via Ritzau

Aug 24, 2026

Aug 24, 2026

Tiziana Life Sciences to present Phase 2a BANYAN trial data at ALS Nexus 2026 - Yahoo Finance

Aug 24, 2026

Aug 24, 2026

Tiziana Life Sciences Announces Poster Presentation on Phase 2a BANYAN Clinical Trial of Intranasal Foralumab at ALS Nexus 2026 - The Manila Times

Aug 24, 2026

Aug 11, 2026

Tiziana Life Sciences Ltd (TLSA) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com

Aug 11, 2026

Aug 07, 2026

Tiziana Life Sciences (TLSA) insider adds 42,357 shares via Panetta Partners - Stock Titan

Aug 07, 2026

Aug 07, 2026

Tiziana Life Sciences Ltd (TLSA) director adds 15,000 shares in open-market buy - Stock Titan

Aug 07, 2026

Aug 07, 2026

Tiziana Life Sciences CEO & Executive Director Acquires 18% More Stock - simplywall.st

Aug 07, 2026

Aug 06, 2026

Tiziana Life Sciences (TLSA) CEO Boosts Stake Amid Unprofitable Operations and Low Valuation - GuruFocus

Aug 06, 2026

Aug 06, 2026

TLSA | Tiziana Life Sciences Ltd. Insider Trading - Quiver Quantitative

Aug 06, 2026

Aug 06, 2026

Insider Buying: Tiziana Life Sciences (NASDAQ:TLSA) CEO Purchases 83,807 Shares of Stock - marketbeat.com

Aug 06, 2026

Aug 06, 2026

Ivor Elrifi Acquires 237,616 Shares of Tiziana Life Sciences (NASDAQ:TLSA) Stock - marketbeat.com

Aug 06, 2026

Aug 06, 2026

Tiziana Life Sciences : Announces Purchase of Shares by Chief Executive Officer - marketscreener.com

Aug 06, 2026

Aug 06, 2026

Tiziana Life Sciences (Nasdaq: TLSA) CEO boosts stake with 321,423-share buy - Stock Titan

Aug 06, 2026

Aug 06, 2026

Tiziana Life Sciences announces CEO share purchase - Proactive financial news

Aug 06, 2026

Aug 06, 2026

Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer - The Manila Times

Aug 06, 2026

Aug 05, 2026

Tiziana Life Sciences (NASDAQ:TLSA) CEO Ivor Elrifi Purchases 667,000 Shares - MarketBeat

Aug 05, 2026

Aug 05, 2026

Tiziana Life Sciences (TLSA) CEO buys 667,000 new shares - Stock Titan

Aug 05, 2026

Aug 05, 2026

Tiziana Life Sciences CEO Boosts Stake as Lead MS Therapy Progresses - The Globe and Mail

Aug 05, 2026

Aug 04, 2026

Tiziana Life Sciences CEO Boosts Stake as Lead MS Therapy Progresses - TipRanks

Aug 04, 2026

Aug 04, 2026

Tiziana Life Sciences (TLSA) CEO Boosts Stake Amid Positive MS T - GuruFocus

Aug 04, 2026

Aug 04, 2026

Tiziana Life Sciences (NASDAQ: TLSA) CEO purchases 667,000 shares at $1 - Stock Titan

Aug 04, 2026

Aug 04, 2026

Tiziana CEO adds to holdings - Proactive financial news

Aug 04, 2026

Aug 04, 2026

Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer - manilatimes.net

Aug 04, 2026

Aug 04, 2026

Tiziana CEO adds to holdings - Proactive financial news

Aug 04, 2026

Aug 03, 2026

Tiziana Life Sciences (TLSA) Slips 5.8% to $0.97, Approaches Key Support at $0.92Reversal Setup Alerts - dars.gov.et

Aug 03, 2026